Vogl SE - Search Results

1

Hexamethylmelamine and low or moderate dose cisplatin with or without pyridoxine for treatment of advanced ovarian carcinoma: a study of the Eastern Cooperative Oncology Group.

Wiernik PH, Yeap B, Vogl SE, Kaplan BH, Comis RL, Falkson G, Davis TE, Fazzini E, Cheuvart B, Horton J. Wiernik PH, et al. Among authors: vogl se. Cancer Invest. 1992;10(1):1-9. doi: 10.3109/07357909209032783. Cancer Invest. 1992. PMID: 1735009 Clinical Trial.

2

High-dose megestrol acetate in the treatment of patients with ovarian cancer who have undergone previous treatment: Eastern Cooperative Oncology Group Study PD884.

Wiernik PH, Greenwald ES, Ball H, Young JA, Vogl S. Wiernik PH, et al. Am J Clin Oncol. 1998 Dec;21(6):565-7. doi: 10.1097/00000421-199812000-00007. Am J Clin Oncol. 1998. PMID: 9856656 Clinical Trial.

3

Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.

Wadler S, Yeap B, Vogl S, Carbone P. Wadler S, et al. Cancer. 1996 Feb 15;77(4):733-42. Cancer. 1996. PMID: 8616766 Clinical Trial.

4

Chemotherapy of advanced head and neck cancer with methotrexate, bleomycin, and cis-diamminedichloroplatinum II in an effective outpatient schedule.

Vogl SE, Kaplan BH. Vogl SE, et al. Cancer. 1979 Jul;44(1):26-31. doi: 10.1002/1097-0142(197907)44:1<26::aid-cncr2820440105>3.0.co;2-w. Cancer. 1979. PMID: 88256 Clinical Trial.

5

The CHAD and HAD regimens in advanced ovarian cancer: combination chemotherapy including cyclophosphamide, hexamethylmelamine, adriamycin, and cis-dichlorodiammineplatinum(II).

Vogl SE, Berenzweig M, Kaplan BH, Moukhtar M, Bulkin W. Vogl SE, et al. Cancer Treat Rep. 1979 Feb;63(2):311-7. Cancer Treat Rep. 1979. PMID: 109202

6

A phase II trial of carboplatin (NSC 241240) in advanced prostate cancer, refractory to hormonal therapy. An Eastern Cooperative Oncology Group pilot study.

Trump DL, Marsh JC, Kvols LK, Citrin D, Davis TE, Hahn RG, Vogl SE. Trump DL, et al. Among authors: vogl se. Invest New Drugs. 1990;8 Suppl 1:S91-4. doi: 10.1007/BF00171992. Invest New Drugs. 1990. PMID: 2199402

7

A randomized prospective comparison of methotrexate with a combination of methotrexate, bleomycin, and cisplatin in head and neck cancer.

Vogl SE, Schoenfeld DA, Kaplan BH, Lerner HJ, Engstrom PF, Horton J. Vogl SE, et al. Cancer. 1985 Aug 1;56(3):432-42. doi: 10.1002/1097-0142(19850801)56:3<432::aid-cncr2820560304>3.0.co;2-x. Cancer. 1985. PMID: 2408735 Clinical Trial.

8

Sequential methotrexate and 5-fluorouracil with bleomycin and cisplatin in the chemotherapy of advanced squamous cancer of the head and neck.

Vogl SE, Komisar A, Kaplan BH, Engstrom PF, Kasule OH, Stolbach L, Lerner H, Muggia F. Vogl SE, et al. Cancer. 1986 Feb 15;57(4):706-10. doi: 10.1002/1097-0142(19860215)57:4<706::aid-cncr2820570404>3.0.co;2-1. Cancer. 1986. PMID: 2417680

9

Pilot study of adriamycin and amsacrine (m-AMSA) in patients with advanced breast cancer.

Chang AY, Solan A, Kaplan BH, Vogl SE, Camacho FJ, Taylor SG 4th. Chang AY, et al. Among authors: vogl se. Am J Clin Oncol. 1988 Oct;11(5):535-7. doi: 10.1097/00000421-198810000-00005. Am J Clin Oncol. 1988. PMID: 3177254

10

Effective chemotherapy for esophageal cancer with methotrexate, bleomycin, and cis-diamminedichloroplatinum II.

Vogl SE, Greenwald E, Kaplan BH. Vogl SE, et al. Cancer. 1981 Dec 15;48(12):2555-8. doi: 10.1002/1097-0142(19811215)48:12<2555::aid-cncr2820481202>3.0.co;2-l. Cancer. 1981. PMID: 6171334

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters